Atlas Trials

A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection

Clinical trial NCT05582694 · WITHDRAWN

Trial details

NCT number
NCT05582694
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multi-Drug Resistant Hiv-1 InfectionHIV-1 Infection
Start date
2025-07-10
Primary completion
2025-07-10
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.